Skip to Main

Emily Serazin joined Boston Consulting Group in 2006. She has been based both in the Washington and Mumbai offices. Emily is a core member of BCG’s Health Care and Social Impact practices. Within health care, Emily’s focus is on vaccines and global health across the value chain. She also has expertise in digital health and in the formation and optimization of public-private partnerships.

Examples of Emily's experience in the commercial health care sector include developing growth and product launch strategies for players in the global vaccines market, leading due diligences, and supporting post-merger integrations. In the realm of global public health, Emily has worked across leading global health institutions such as Gavi, UNICEF, WHO, and the Bill & Melinda Gates foundation to define investment strategies, coordinate multistakeholder efforts, prioritize portfolios, and identify key levers to drive uptake in low- and middle-income countries.

AREAS OF EXPERTISE

EDUCATION

  • MPhil, Rhodes Scholar, University of Oxford
  • BA, Summa Cum Laude, Williams College

HONORS AND AWARDS

  • Rhodes Scholarship

Publications and Videos

" "

Addressing Challenges at the Intersection of Climate and Health

BCG conducted a study of more than 70 organizations—including philanthropies, multilateral development banks, government agencies, nongovernmental organizations, private sector actors, and others—to understand how key stakeholders are approaching the climate-health challenge.

" "

Unlocking the Potential of AI in Drug Discovery

This report examines AI's potential in drug discovery, exploring key applications, assessing maturity, identifying barriers, and proposing solutions. It emphasizes the crucial role of health research funders in shaping this dynamic field to address urgent health needs equitably.

How Public Health Leaders Can Fight the Next Pandemic | rectangle

How Public-Health Leaders Can Fight the Next Pandemic

COVID-19 offered valuable lessons in combating epidemic-level disease. Four measures can help institutionalize what we’ve learned.
Ramping Up Vaccine Manufacturing in Africa | rectangle

Ramping Up Vaccine Manufacturing in Africa

Stakeholder support is crucial for ensuring that African vaccine-manufacturing companies can produce sufficient supply for the continent.
vaccinating nations.png

Vaccinating Nations: Country Planning for an Unprecedented Immunization Campaign

The pandemic has exposed weaknesses in countries' health systems. Mid- to long-term planning for vaccines and beyond is necessary as the world moves toward controlling a virus that will be endemic.
" "

Vaccines to tackle drug resistant infections

Antimicrobial resistance is difficult to combat. This report gives a comprehensive assessment of vaccine R&D potential against pathogens with high levels of AMR.
Winning-the-Fight-Against-Endemic-COVID-19.jpg

Winning the Fight Against Endemic COVID-19

COVID-19 will likely become endemic. If so, a global surveillance, treatment and vaccination infrastructure for monitoring and responding to outbreaks must be developed now.
Image of a Masked Woman Administering a Medical Vaccine into Someone's Arm

A Vaccination Strategy to Save Lives and Livelihoods

Protecting the health-vulnerable population first can shave months off a country’s reopening.
Image of a Hand Under a Faucet Running Water

Vaccines Aren’t the End of the Fight, but the End of the Beginning

Governments cannot let the most vulnerable be the least protected again. Countries, regions, and states can still get the rollout right through science, hard work, and vigilance.
timelines-and-implications-for-covid-19-vaccines-rectangle-tcm9-246655.jpg

The Timelines and Implications for COVID-19 Vaccines

A 12- to 18-month timeline assumes that a vaccine progresses through all the various stages of testing without encountering significant issues.
Tech Disruption Comes to Global Sanitation - Rectangle

Tech Disruption Comes to Global Sanitation

The humble toilet is undergoing a transformation, unlocking a vast new opportunity—not just to capture value but also to change lives.
eyeem-2880x1620-tcm9-189233.jpg

A Prescription for Blockchain in Health Care

Commercial applications are poised to go mainstream. Pharma and medtech companies, payers, and providers need to engage with the technology now.